Particle.news

Download on the App Store

Government Audit Finds 27% Overpricing in ANDIS Drug Purchase

The interventor ordered a comparative review of seven high-cost medicines, with a broader audit now underway.

Image
Diego Spagnuolo, ex titular de la Andis.
Image

Overview

  • Preliminary data show Incluir Salud paid ARS 13,500,176 in August 2025 for PEG Asparaginasa versus ARS 8,274,027 paid by the Health Ministry a year earlier, a 27% premium after adjusting for inflation.
  • Both transactions were supplied by Droguería Suizo Argentina, a major distributor that holds multiple national contracts recorded on the COMPR.AR platform.
  • The government presented the figure as its first official confirmation of overpricing since the scandal that prompted the removal of Diego Spagnuolo from ANDIS.
  • Alejandro Vilches, formerly a senior Health Ministry official, was named interventor as the administration moves to place the agency under direct ministerial control.
  • President Javier Milei dismissed Spagnuolo’s claims and said he would take the case to the courts, while authorities continue the procurement audit.